References
- HatzimouratidisKHatzichristouDSexual dysfunctions: classifications and definitionsJ Sex Med20074124125017233791
- DusingRSexual dysfunction in male patients with hypertension: influence of antihypertensive drugsDrugs200565677378615819590
- KlonerRErectile dysfunction and hypertensionInt J Impot Res200719329630217151696
- StadlerTBaderMUckertSStaehlerMBeckerAStiefCGAdverse effects of drug therapies on male and female sexual functionWorld J Urol20061224662362917091248
- KlonerRAMullinSHShookTErectile dysfunction in the cardiac patient: how common and should we treat?J Urol.20031702 Pt 2 Suppl4650
- PapatsorisAGKorantzopoulosPGHypertension, antihypertensive therapy, and erectile dysfunctionAngiology2006571475216444456
- ReffelmannTKlonerRASexual function in hypertensive patients receiving treatmentVasc Health Risk Manag20062444745517323599
- FogariRZoppiAPolettiLMarasiGMugelliniACorradiLSexual activity in hypertensive men treated with valsartan or carvedilol: a crossover studyAm J Hypertens2001141273111206674
- LlisterriJLLozano VidalJVAznar VicenteJSexual dysfunction in hypertensive patients treated with losartanAm J Med Sci2001321533634111370797
- Della ChiesaAPfiffnerDMeierBHessOMSexual activity in hypertensive menJ Hum Hypertens200317851552112874608
- BateALindquistMEdwardsIRA Bayesian neural network method for adverse drug reaction signal generationEur J Clin Pharmacol19985443153219696956
- BateALindquistMOrreREdwardsIRMeyboomRHData-mining analyses of pharmacovigilance signals in relation to relevant comparison drugsEur J Clin Pharmacol200258748349012389072
- van PuijenbroekEPBateALeufkensHGLindquistMOrreREgbertsACA comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiol Drug Saf200211131011998548
- LindquistMEdwardsIRBateAFucikHNunesAMStahlMFrom association to alert – a revised approach to international signal analysisPharmacoepidemiol Drug Saf19998Suppl 1S15S2515073883
- RosenRCMarinHPrevalence of antidepressant-associated erectile dysfunctionJ Clin Psychiatry200364Suppl 1051012971810
- GroverSALowensteynIKaouacheMThe prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular diseaseArch Intern Med2006166221321916432091
- WallensteinEJFifeDTemporal patterns of NSAID spontaneous adverse event reports: the Weber effect revisitedDrug Saf200124323323711347725
- McAdamsMAGovernaleLASwartzLHammadTADal PanGJIdentifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effectPharmacoepidemiol Drug Saf200817988288918636418
- BeckerAJUckertSStiefCGPossible role of bradykinin and angiotensin II in the regulation of penile erection and detumescenceUrology200157119319811164180
- ChenYLiSXYaoLSWangRDaiYTValsartan treatment reverses erectile dysfunction in diabetic ratsInt J Impot Res200719436637017183345
- Alvarez-RequejoACarvajalABegaudBMorideYVegaTAriasLHUnder-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel systemEur J Clin Pharmacol19985464834889776440
- EkmanEBackstromMAttitudes among hospital physicians to the reporting of adverse drug reactions in SwedenEur J Clin Pharmacol2009651434618825377
- TomlinsonJABC of sexual health: taking a sexual historyBMJ19983177172157315769836664